May 20, 2020, 09:15 EST
May 20, 2020, 09:15 /Comserve / -- Activ Surgical Inc. announced its new platform, ActivEdge, which is developed for improving surgical outcomes through the utilization of artificial intelligence as well as machine learning.
Activ Surgical Inc. announced its new platform, ActivEdge, which is developed for improving surgical outcomes through the utilization of artificial intelligence as well as machine learning.
This new development in technology would create a significant impact on the healthcare industry as the robotics precision would drastically minimize the surgical errors that are unavoidable by the human hand. Apart from the increased safety, the ActivEdge platform will ensure that real-time information is provided to the surgeons and other medical professionals involved so that they are able to study the case properly and make better informed decisions.
This platform consists of a product portfolio made up of computer-driven hardware systems and hardware-agnostic imaging software. It can be used for surgical robots and scopes during surgical operations. The real-time imaging provides a clearer access to the body tissues and allows the procedure to be carried out in a safe manner. This technique is predicted to be tested on various common laparoscopic procedures at the beginning, including colectomy, gastrectomy, cholecystectomy, hysterectomy among others, in order to study the outcomes better.
On the other hand, there are other numerous products associated with the use of artificial intelligence and machine learning to collect medical data and provide augmented visuals to the medical professionals are being developed by the company. ActivAssist and ActivPilot are two such platforms that would provide robot-assisted surgery. ActivInsight, the platform containing data sets, would be used by ActivAssist to position scopes through machine learning technologies. ActivPilot is being developed to perform a number of autonomous medical procedures with a surgeon to provide best surgical outcomes to the patients.
The company is planning to launch the ActivEdge platform by the end of this year in the United States, and by the end of the next year globally.
For more information, please contact:Jackie Hurtado
News Updates on Industries
The announcement was made by Diverse Biotech, Inc. about its selection for presenting paper for the
The company plans to manufacture styrene monomer and propylene oxide as a part of this joint venture